Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Pelvic Pain
NCT03782740Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- Mar 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of melatonin in dysmenorrhea and endometriosis (4 arms), sponsored by Karolinska Institutet. Primary endpoint: Pain reduction at 12 weeks. Started Mar 2019; status: completed.
02
Drugs
melatonin
03
Conditions
dysmenorrheaendometriosis
Beyond the preview
Go deeper on NCT03782740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03782740.